| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR and Western Blotting and IF staining | NA | 0.72 | 0.5461 | 28076840
|
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.72 | 0.5461 | 32189359
|
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | qRT-PCR and Western Blotting | NA | 0.72 | 0.5461 | 32638620
|
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.72 | 0.5461 | 28415621
|
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.72 | 0.5461 | 27524415
|
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.72 | 0.5461 | 28529558
|
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qPCR | NA | 0.72 | 0.5461 | 28428713
|
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by RT-PCR | NA | 0.72 | 0.5461 | 24573253
|
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | FACs followed by SFA | NA | 0.72 | 0.5461 | 28893318
|
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | ALDEFLUOR assay followed by qRT-PCR and Western Blotting | NA | 0.6 | 0.684 | 32638620
|
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.6 | 0.684 | 27524415
|
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.6 | 0.684 | 28337375
|
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.6 | 0.684 | 28336807
|
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA and FACs followed by qRT-PCR and Western Blotting | NA | 0.6 | 1 | 33608016
|
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qPCR and Western Blotting | NA | 0.6 | 1 | 28428713
|
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.6 | 1 | 28893318
|
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.6 | 1 | 32142918
|
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by RT-PCR | NA | 0.6 | 1 | 24573253
|
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA and FACs | NA | 0.6 | 1 | 34075691
|
| PMP22 | 9118 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qPCR and Western Blotting and FACs | NA | 0.6 | 0.0011 | 28336807
|
| BMI1 | 1066 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.1135 | 28415621
|
| DDIT3 | 2726 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0032 | 32189359
|
| HMGA2 | 5009 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0042 | 28337375
|
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 28076840
|
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 32189359
|
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 32638620
|
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 32638620
|
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.6448 | 28415621
|
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 27524415
|
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 28337375
|
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 28529558
|
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qPCR | NA | 0.48 | 0.6448 | 28428713
|
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 28893318
|
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.7582 | 32189359
|
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | qRT-PCR and Western Blotting | NA | 0.48 | 0.7582 | 32638620
|
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.7582 | 28415621
|
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA and FACs | NA | 0.48 | 0.7582 | 34075691
|
| SNAI1 | 11128 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA and qRT-PCR followed by Western Blotting | NA | 0.48 | 0.0212 | 33608016
|
| SNAI2 | 11094 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA and qRT-PCR followed by Western Blotting | NA | 0.48 | 0.0159 | 33608016
|
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 32189359
|
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 32638620
|
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.5695 | 28415621
|
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5695 | 28337375
|
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5695 | 28529558
|
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | Western Blotting | NA | 0.48 | 0.5695 | 32724313
|
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qPCR | NA | 0.48 | 0.5695 | 28428713
|
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.5695 | 28893318
|
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.5695 | 32142918
|
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qPCR | NA | 0.48 | 0.5695 | 28336807
|
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by RT-PCR | NA | 0.48 | 0.5695 | 24573253
|
| TWIST1 | 12428 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA and qRT-PCR followed by Western Blotting | NA | 0.48 | 0.0191 | 33608016
|
| USP22 | 12621 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.0032 | 28415621
|
| DPP4 | 3009 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0085 | 27524415
|
| ID1 | 5360 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0053 | 28529558
|
| MTDH | 29608 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | Western Blotting followed by CFA | NA | 0.28 | 0.0011 | 31632151
|
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 28337375
|
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.1304 | 32142918
|
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qPCR | NA | 0.28 | 0.1304 | 28336807
|
| ABCC1 | 51 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0212 | 28893318
|
| ABCC1 | 51 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0212 | 24573253
|
| ABCC2 | 53 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0106 | 28893318
|
| ABCC3 | 54 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0042 | 28893318
|
| ABCC4 | 55 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0042 | 28893318
|
| ABCC5 | 56 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0053 | 28893318
|
| ABCC5 | 56 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0053 | 24573253
|
| ABCG2 | 74 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.1739 | 28893318
|
| ABCG2 | 74 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.1739 | 24573253
|
| BIRC5 | 593 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0053 | 28893318
|
| DDR1 | 2730 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qPCR | NA | 0.2 | 0.0032 | 28336807
|
| FEZF1-AS1 | 41001 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | qRT-PCR | NA | 0.2 | 0.0021 | 32638620
|
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0891 | 32142918
|
| LGR5 | 4504 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | RT-PCR | NA | 0.2 | 0.0753 | 32724313
|
| NANOGP8 | 23106 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by qPCR | NA | 0.2 | 0.0011 | 29689047
|
| THY1 | 11801 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0371 | 24573253
|
| CXCR4 | 2561 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | FACs followed by SFA | NA | 0.12 | 0.0498 | 27524415
|
| EPCAM | 11529 | LTM | Gastric Cancer | Adenocarcinoma | MGC-803 | NA | SFA and FACs | NA | 0.12 | 0.211 | 33608016
|